Structures by: Pavic A.
Total: 11
0.25(C32H24Ag4N12O12)
0.25(C32H24Ag4N12O12)
Med. Chem. Commun. (2016) 7, 2 282
a=13.678(5)Å b=10.566(5)Å c=12.076(5)Å
α=90° β=90° γ=90°
C20H18Ag2N6,2(BF4)
C20H18Ag2N6,2(BF4)
Med. Chem. Commun. (2016) 7, 2 282
a=7.544(3)Å b=8.109(4)Å c=11.175(5)Å
α=110.495(12)° β=99.220(9)° γ=98.036(11)°
C11H17AuClN4O3,Cl,2(H2O)
C11H17AuClN4O3,Cl,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2594-2608
a=6.9310(4)Å b=11.7421(7)Å c=12.5963(8)Å
α=68.927(6)° β=79.453(5)° γ=88.221(5)°
C12H19AuClN4O3,Cl
C12H19AuClN4O3,Cl
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2594-2608
a=9.8509(2)Å b=10.7911(2)Å c=15.3736(3)Å
α=90° β=90° γ=90°
C12H19AuClN4O3,AuCl4,H2O
C12H19AuClN4O3,AuCl4,H2O
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2594-2608
a=8.35190(10)Å b=11.12680(10)Å c=24.3707(2)Å
α=90° β=90° γ=90°
C9H13AuClN4O3,AuCl4,H2O
C9H13AuClN4O3,AuCl4,H2O
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2594-2608
a=27.3091(7)Å b=8.6678(2)Å c=8.6743(2)Å
α=90° β=108.081(2)° γ=90°
C12H12Cl3NO2PtS,1/3(C3H6O)
C12H12Cl3NO2PtS,1/3(C3H6O)
Inorganic Chemistry Frontiers (2018) 5, 1 39
a=23.9829(5)Å b=10.1789(3)Å c=20.8153(5)Å
α=90° β=103.822(2)° γ=90°
C15H16Cl2IN4OPPt
C15H16Cl2IN4OPPt
Inorganic Chemistry Frontiers (2018) 5, 1 39
a=5.810(5)Å b=12.770(5)Å c=12.865(5)Å
α=84.543(5)° β=81.308(5)° γ=78.412(5)°
C11H11ClN2O4PtS
C11H11ClN2O4PtS
Inorganic Chemistry Frontiers (2018) 5, 1 39
a=9.4359(6)Å b=6.7378(4)Å c=10.5414(5)Å
α=90° β=97.352(5)° γ=90°
C15H16ClI2N4OPPt
C15H16ClI2N4OPPt
Inorganic Chemistry Frontiers (2018) 5, 1 39
a=5.8236(3)Å b=9.9683(6)Å c=17.4696(9)Å
α=86.328(4)° β=88.630(4)° γ=73.328(5)°
C11H11ClN2O4PtS,CH2Cl2
C11H11ClN2O4PtS,CH2Cl2
Inorganic Chemistry Frontiers (2018) 5, 1 39
a=19.3571(7)Å b=6.8349(3)Å c=25.1990(10)Å
α=90° β=95.245(4)° γ=90°